High-Throughput Identification of Tissue/Cell-Type-Specific Cis Regulatory Module
组织/细胞类型特异性顺式调控模块的高通量鉴定
基本信息
- 批准号:8004415
- 负责人:
- 金额:$ 57.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-27 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultApplications GrantsBenchmarkingBinding SitesBiologicalBiological AssayBiological ModelsBiologyBostonCardiacCardiac MyoblastsCell fusionCellsChildCodeConsultationsDNA BindingDNA analysisDataDevelopmentDictionaryDrosophila genusEducational workshopElectronic MailEmbryoEnhancersExtramural ActivitiesFundingGene ExpressionGene Expression RegulationGene TargetingGenerationsGenesGeneticGenomicsGoalsGrantGuidelinesHeartHeart DiseasesHuman ResourcesIndiumLaboratoriesLeadershipLettersMesodermMesoderm CellMuscle DevelopmentMuscular DystrophiesMutationMyoblastsMyocardiumNational Heart, Lung, and Blood InstituteNational Human Genome Research InstituteNatural regenerationOrganismParticipantPathway interactionsPericardial body locationPersonsRNA InterferenceResearch PersonnelResolutionResourcesSignal TransductionSpecificityStretchingSurveysSystemTechniquesTechnologyTelephoneTestingTimeTissuesUnited States National Institutes of HealthValidationVertebratesVisitWorkbasecell typecombinatorialcongenital heart disorderflygain of functionhigh throughput technologyin vivoloss of functionmembermutantnew technologynovelpublic health relevanceresearch studytechnology developmenttooltranscription factor
项目摘要
In metazoans, gene expression is regulated in a tissue/cell-type specific manner
predominantly via stretches of noncoding sequence referred to as cis regulatory
modules (CRMs) that regulate the expression of (typically) the adjacent gene(s). CRMs
usually contain 1 or more DNA binding sites for 1 or more sequence-specific, regulatory
transcription factors (TFs) that function to activate or repress the target gene(s); CRMs
that activate gene expression are frequently referred to as "transcriptional enhancers",
and have been the focus of many computational and experimental studies. Identification
of tissue/cell-type-specific enhancers in metazoans remains a significant challenge.
Moreover, despite recent technological advances, a major, rate-limiting bottleneck that is
impeding rapid progress in the field is the still quite low-throughput experimental testing
of candidate enhancers.
The overarching goals of this project are to develop and apply novel 'wet-lab' technology
for high-throughput experimental identification of tissue/cell-type-specific transcriptional
enhancers. In this project we will focus on the developing embryonic mesoderm in
Drosophila as a model system. We will identify cis regulatory modules and analyze their
constituent cis regulatory codes that operate in somatic mesoderm (SM) founder cells
(FCs) and fusion competent myoblasts (FCMs). Specifically, we will: develop and apply
novel 'wet-lab' technology for high-throughput experimental identification of tissue/cell-
type-specific transcriptional enhancers; determine the DNA binding specificities of ~75
known and predicted TFs expressed in the Drosophila embryonic mesoderm; predict
CRMs and infer cis regulatory codes considering highly combinatorial input from large,
high-resolution TF-DNA binding specificity dictionaries; and experimentally validate
newly discovered enhancers. Importantly, we anticipate that the technologies,
approaches, tools, and data resulting from this project will be generally applicable to
other systems and organisms.
在后生动物中,基因表达以组织/细胞类型特异性方式调节
主要通过称为顺式调节的非编码序列延伸
调节(通常)相邻基因表达的模块(CRM)。客户关系管理系统
通常包含 1 个或多个 DNA 结合位点,用于 1 个或多个序列特异性、调节性
具有激活或抑制靶基因功能的转录因子 (TF);客户关系管理系统
激活基因表达的物质通常被称为“转录增强子”,
并已成为许多计算和实验研究的焦点。鉴别
后生动物中组织/细胞类型特异性增强剂的研究仍然是一个重大挑战。
此外,尽管最近技术取得了进步,但一个主要的速率限制瓶颈是
阻碍该领域快速进展的是仍然相当低通量的实验测试
候选增强子。
该项目的总体目标是开发和应用新型“湿实验室”技术
用于组织/细胞类型特异性转录的高通量实验鉴定
增强剂。在这个项目中,我们将重点关注胚胎中胚层的发育
果蝇作为模型系统。我们将识别顺式监管模块并分析其
在体细胞中胚层 (SM) 创始细胞中运行的顺式组成调控代码
(FC)和具有融合能力的成肌细胞(FCM)。具体来说,我们将: 开发和应用
新颖的“湿实验室”技术,用于组织/细胞的高通量实验鉴定
类型特异性转录增强子;确定约 75 的 DNA 结合特异性
果蝇胚胎中胚层中表达的已知和预测的 TF;预测
CRM 和推断顺式监管代码考虑了来自大型、
高分辨率 TF-DNA 结合特异性字典;并通过实验验证
新发现的增强子。重要的是,我们预计这些技术,
该项目产生的方法、工具和数据将普遍适用于
其他系统和生物体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTHA L BULYK其他文献
MARTHA L BULYK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTHA L BULYK', 18)}}的其他基金
Influences of DNA sequence and histone features on transcription factor binding to nucleosomes
DNA 序列和组蛋白特征对转录因子与核小体结合的影响
- 批准号:
10528812 - 财政年份:2022
- 资助金额:
$ 57.44万 - 项目类别:
Influences of DNA sequence and histone features on transcription factor binding to nucleosomes
DNA 序列和组蛋白特征对转录因子与核小体结合的影响
- 批准号:
10688104 - 财政年份:2022
- 资助金额:
$ 57.44万 - 项目类别:
Transcription factor mutationsunderlying birth defects or pediatric cancers
出生缺陷或儿科癌症背后的转录因子突变
- 批准号:
10004146 - 财政年份:2019
- 资助金额:
$ 57.44万 - 项目类别:
Transcription factor mutationsunderlying birth defects or pediatric cancers
出生缺陷或儿科癌症背后的转录因子突变
- 批准号:
9807965 - 财政年份:2019
- 资助金额:
$ 57.44万 - 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
- 批准号:
10112946 - 财政年份:2019
- 资助金额:
$ 57.44万 - 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
- 批准号:
9923713 - 财政年份:2019
- 资助金额:
$ 57.44万 - 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
- 批准号:
10368951 - 财政年份:2019
- 资助金额:
$ 57.44万 - 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
- 批准号:
10561151 - 财政年份:2019
- 资助金额:
$ 57.44万 - 项目类别:
AVATAR: highly parallel analysis of variation in transcription factors and their DNA binding sites
AVATAR:转录因子及其 DNA 结合位点变异的高度并行分析
- 批准号:
9767247 - 财政年份:2018
- 资助金额:
$ 57.44万 - 项目类别:
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
转录因子同工型对乳腺癌调控网络的重新布线
- 批准号:
10249199 - 财政年份:2018
- 资助金额:
$ 57.44万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




